← Back to Insights
December 12, 2019
Authors
Alina-Bonn
Topics
Economics Innovation
Channels
4sight Radio & TV Interviews Podcasts

Podcast: Commercializing Breakthrough Drugs in a Value-Based Market

What does it take to bring a breakthrough drug to a value-based market? John Kerins, Director at Cain Brothers, a division of KeyBanc Capital Markets Inc., and David Johnson discuss the intensified need for data, collaboration and communication to bring exceptionally costly but desperately needed therapies to market. They hone in on the growing role of medical affairs and contract commercialization services organizations in meeting the needs of all stakeholders for value.

John and Dave also co-authored a detailed article on the topic. Read it here.

About the Author

Alina-Bonn

Alina focuses on copywriting, email marketing, social media campaigns and other marketing strategies for 4sight Health. Alina is passionate about helping entrepreneurs and service-based businesses increase revenue with digital and social media marketing solutions. Her professional background blends marketing, event management and business administration.

Before 4sight Health, Alina helped other business consultants and professional speakers grow their businesses online. Prior to that, she was a conference coordinator at an international finance association in Manhattan.

Alina received her Bachelor’s in business administration from The King’s College, a classical liberal arts school near Wall St. She now lives in her hometown of Omaha, NE, where she continues to learn top marketing strategies from industry leaders in digital classrooms. Alina enjoys running races, exploring greenhouses and planning new travels.

Recent Posts

System Dynamics
4sight Friday | Getting Healthcare Unstuck | Private Equity Is What Private Equity Does | The Uninsured. Anyone? Anyone?
Read the 9/28/2023 Edition here. Subscribe here for weekly access. Curated by David Burda, 4sight Health’s news editor… Read More
By September 28, 2023
Innovation
Podcast: Private Equity, Antitrust and Ownership Transparency 9/28/23
How can we ensure that private equity investment in healthcare is used for good, not evil? Government regulation?… Read More
By September 28, 2023
Policy
Do We Still Care About the Uninsured?
Were you better off in 2022 than you were in 2017? I was for a lot of reasons…. Read More
By September 27, 2023